semaglutide for prediabetes Efficacy and safety of once-weekly 2·4 mg versus placebo in people with obesity and (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial Editors Choice Dost Ongur.mp4

Look for cloudiness, particles, color changes, or sediment

The NDA for Wegovy was submitted in December 2020, before the pivotal trial was even published

Yes SCFAs improve mitochondrial activity, enhance fat oxidation, and strengthen metabolic flexibility

Introduction Did you know that a significant percentage of patients using GLP-1 medications for weight loss may unknowingly be at risk of developing acute pancreatitis

B2 cells that participate in the immune system are pro-inflammatory factors that can promote NASH-associated liver fibrosis ( H 2 and T H 17 cells have a pro-fibrogenic impact ( H 17 can stimulate the formation of transforming growth factor- (TGF-), which promotes fibrosis by activating fibroblasts ( + PD1 + T cells in mice and humans with NASH (Pfister et al., 2021)